Event Description

Studies have shown that ChatGPT — a generative AI chatbot — can help to diagnose a number of medical conditions. But generative AI is just one buzzy development in a field already crowded with technologies that promise to move diagnosis out of the confines of the clinic and into the homes of patients. Companies are developing tools that can assist physicians, patients, and consumers in diagnosing diseases or conditions. While impressive, these technologies raise a variety of legal and ethical issues. To discuss the current state of technology, potential future developments, and the legal and ethical issues raised by digital diagnostic technologies, Adam Landman, Michael Abramoff, and Leah Fowler will participate in a discussion moderated by David Simon. 

Panelists

• Welcome: I. Glenn Cohen, Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and James A. Attwood and Leslie Williams Professor of Law, and Deputy Dean, Harvard Law School
• Adam Landman, Chief Medical Information Officer, Health Information Innovation and Integration and Associate Professor of Emergency Medicine, Brigham and Women’s Hospital 
• Michael Abramoff, The Robert C. Watzke, MD Professor in Retina Research, Professor of Ophthalmology and Visual Sciences, Professor of Electrical and Computer Engineering, and Professor of Biomedical Engineering, Carver College of Medicine, University of Iowa
• Leah Fowler, Research Assistant Professor and Research Director, Health Law & Policy Institute, The University of Houston Law Center
• Moderator: David Simon, Associate Professor of Law, Northeastern University School of Law

Sponsored by Diagnosing in the Home: The Ethical, Legal, and Regulatory Challenges and Opportunities of Digital Home Health at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with generous support from the Gordon and Betty Moore Foundation and the Oswald DeN. Cammann Fund at Harvard University.